Phenomics Health Inc. – Trademark Portfolio
Entity Type: 03
Phenomics Health Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include PRECERA, SYNCVIEW, PRECISMED, PRECISVIEW, and PREDICTSCRIPT. The owner is based in Hilton Head Island, SC.
60 Yorkshire Drive
Hilton Head Island, SC 29928
Showing of trademarks Trademarks
Trademark Classifications
Phenomics Health Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Phenomics Health Inc. have?
Phenomics Health Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending, 2 abandoned, 1 cancelled.
What trademark classes does Phenomics Health Inc. file in?
Phenomics Health Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Phenomics Health Inc.'s most well-known trademarks?
Phenomics Health Inc.'s registered trademark portfolio includes well-known marks such as PRECERA, SYNCVIEW, PRECISMED, PRECISVIEW, and PREDICTSCRIPT. These are among 6 currently registered trademarks in the portfolio.
What is Phenomics Health Inc.'s trademark registration success rate?
Phenomics Health Inc. has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 2 applications are pending review.